chronic myeloid leukemia

Why Ariad Pharmaceuticals' Shares Dropped
Motley Fool
Sat, 12/15/12 - 11:30 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
leukemia
acute lymphoblastic leukemia
Ariad Sinks on Safety Warnings With U.S. Drug Approval
Bloomberg
Sat, 12/15/12 - 11:25 am
Ariad Pharmaceuticals
Iclusig
leukemia
acute lymphoblastic leukemia
chronic myeloid leukemia
Ariad Wins Approval for Drug to Treat Rare Leukemias, FDA Says
Bloomberg
Fri, 12/14/12 - 12:31 pm
Ariad Pharmaceuticals
FDA
chronic myeloid leukemia
Iclusig
ARIAD Announces 12-Month Data from Pivotal PACE Trial of Ponatinib in Heavily Pretreated Chronic-Phase CML Patients
Yahoo/BusinessWire
Sun, 12/9/12 - 01:16 pm
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
FDA Agrees to Speed Review of Ariad Drug
Motley Fool
Fri, 10/26/12 - 11:15 am
FDA
Ariad Pharma
Ponatinib
chronic myeloid leukemia
acute lymphoblastic leukemia
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
news-medical.net
Sat, 06/16/12 - 02:12 pm
Otsuka
Bristol-Myers Squibb
Sprycel
leukemia
chronic myeloid leukemia
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Kedem Pharma begins development of anti-cancer drug, Gleevec
Pharmabiz
Sat, 01/14/12 - 12:37 pm
Kedem Pharmaceuticals
Gleevec
chronic myeloid leukemia
Ariad leukemia drug helps 47 pct of patients -study
Reuters
Mon, 12/12/11 - 10:46 am
Ariad Pharmaceuticals
Ponatinib
chronic myeloid leukemia
Pfizer says EU starts review of 2 cancer drugs
Yahoo/AP
Wed, 08/17/11 - 05:20 pm
Europe
Pfizer
crizotinib
Bosutinib
lung cancer
chronic myeloid leukemia
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Yahoo/PR NewsWire
Mon, 01/31/11 - 07:46 am
Inovio
acute myeloid leukemia
chronic myeloid leukemia
leukemia
Elgen 1000
cancer vaccines
Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
Yahoo/PR NewsWire
Sat, 12/4/10 - 12:17 pm
Pfizer
Bosutinib
chronic myeloid leukemia
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Sat, 10/23/10 - 12:42 pm
Bristol-Myers Squibb
pegylated interferon lambda
hepatitis C
Sprycel
chronic myeloid leukemia
Onglyza
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Sat, 07/10/10 - 11:39 am
Sprycel
chronic myeloid leukemia
BMS
Otsuka
SPRYCEL(R) (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec(R)* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
BusinessWire
Sat, 06/5/10 - 12:24 pm
chronic myeloid leukemia
Sprycel
dasatinib
Gleevac
BMS
Otsuka

Pages